PartsTable TECHNICAL DATA SHEET
NSN 6505-01-354-6310Government record, cited

Magnesium Sulfate Injection6505-01-354-6310

NSN 6505-01-354-6310 · NIIN 013546310
FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment
Government record, cited
Also searched as  6505-01-354-6310 · 6505013546310 · NIIN 013546310 · 01-354-6310 · FSC 6505 Drugs and Biologicals · 96402 · NDC00469-6400-15
Nearby stock numbers  ·
Features
  • Magnesium Sulfate Injection — FSC 6505
  • Primary Container Content Quantity: 2.000 MILLILITERS
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Primary Container Type: VIAL
  • Pharmaceutical Vehicle Type: AQUEOUS
  • Active Medicament Medicinal Strength: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
  • Total Primary Container Quantity: 25
Identification
  • NSN: 6505-01-354-6310
  • NIIN: 013546310
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
General Description

The Magnesium Sulfate Injection, cataloged under National Stock Number 6505-01-354-6310, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 6 specifications, cited from the U.S. Government catalog. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.

Technical Specifications
ParameterValue
NSN6505-01-354-6310
Item NameMagnesium Sulfate Injection
FSC / FSG6505 / 65 — Drugs and Biologicals
StatusACTIVE
Primary Container Content Quantity2.000 MILLILITERS
Medical Designation and GradeUNITED STATES PHARMACOPEIA
Primary Container TypeVIAL
Pharmaceutical Vehicle TypeAQUEOUS
Active Medicament Medicinal Strength50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
Total Primary Container Quantity25
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardPossible hazard — SDS may be required (DLA HMIC P)
Criticality CodeX
Cross-Reference Index
No manufacturer part numbers on file in the U.S. Government catalog.
Reference documents
ReferenceMeaning
96402 3/9 Design control — primary reference
Lyphomed Inc Div of Fujisawa Usa Inc
NDC00469-6400-15 5/9 Secondary reference
Lyphomed Inc Div of Fujisawa Usa Inc

Frequently Asked Questions

What is NSN 6505-01-354-6310?

NSN 6505-01-354-6310 is a Magnesium Sulfate Injection, classified under FSC 6505, Drugs and Biologicals. Status: active.

What are the specifications of 6505-01-354-6310?

Key specifications for 6505-01-354-6310: Primary Container Content Quantity: 2.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL; Pharmaceutical Vehicle Type: AQUEOUS. 6 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-354-6310 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com